Loading clinical trials...
Loading clinical trials...
The second generation of mesothelin targeted CAR-T cells that secret a fusion protein of IL21 and scfv against PD1 have been constructed and their anti-cancer function has been verified by multiple in...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Second Affiliated Hospital of Guangzhou Medical University
Collaborators
NCT04485286 · Lung Cancer, Radiation Fibrosis, and more
NCT04605913 · Pancreas Cancer, Metastatic Pancreatic Cancer, and more
NCT07433283 · Tumor, Solid, Lung Cancer, and more
NCT06051695 · Solid Tumor, Adult, Colorectal Cancer, and more
NCT06242470 · Advanced Solid Tumor, Advanced Cancer, and more
The Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions